Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 20.3% | 27.7% | 20.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.7% | 42.6% | 36.6% | 41.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.8% | -56.5% | -71.1% | -104% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.6% | -66.7% | -83.5% | -107% |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 |
| % Growth | 63.9% | 0% | 10.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |